Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Icagen, Inc. | f8k030413_caldera.htm |
EXHIBIT 16.1
March 8, 2013
Securities and Exchange Commission
100 F Street, N.W.
Washington, DC
Dear Sirs/Madams:
We have read Item 4.01 of the Caldera Pharmaceuticals, Inc. Form 8-K dated March 4, 2013, and agree with the statements concerning our firm contained therein.
Very truly yours,
/s/ Sherb & Co., LLP